# SFXN2

## Overview
SFXN2, or sideroflexin 2, is a gene that encodes a mitochondrial transmembrane protein involved in iron metabolism and heme biosynthesis. The protein, also named sideroflexin 2, is characterized by its five transmembrane domains and is primarily localized to the mitochondrial outer membrane, where it plays a critical role in maintaining mitochondrial iron homeostasis and facilitating the transport of serine and other metabolites. This function is essential for one-carbon metabolism and cellular respiration, highlighting its importance in energy production and redox homeostasis (Chen2022Elevated; Mon2018Regulation). SFXN2 is part of the SLC56 family and is distinct from the mitochondrial carrier family, indicating its unique role in cellular metabolism (Chen2022Elevated). The gene's expression is notably high in the liver and kidney, organs with significant heme-synthesizing capacity, and its dysregulation has been implicated in various cancers, including multiple myeloma and breast cancer, where it may influence cancer progression and prognosis differently (Yuan2023Comprehensive; Mon2018Regulation).

## Structure
Sideroflexin 2 (SFXN2) is a mitochondrial protein characterized by its five transmembrane domains, which are integral to its function in mitochondrial iron metabolism and heme biosynthesis (Attwood2021Characterization; Mon2018Regulation). The primary structure of SFXN2 includes a long N-terminal region of approximately 100 amino acids and a short C-terminus of about 40 amino acids, with the final eight amino acids being highly conserved across species, indicating evolutionary conservation (Mon2018Regulation). 

The protein is localized to the mitochondrial outer membrane, and its transmembrane domains likely serve as mitochondrial targeting signals (Chen2022Elevated; Mon2018Regulation). SFXN2 is part of the SFXN protein family, which is distinct from the mitochondrial carrier family and is categorized under the SLC56 family (Chen2022Elevated). 

Post-translational modifications of SFXN2 may include acetylation at the N-terminal region, which could influence its subcellular localization and function (Attwood2021Characterization). The protein's structure and function are conserved across various species, with vertebrates and invertebrates showing significant similarity to human SFXN2 (Mon2018Regulation).

## Function
SFXN2 (sideroflexin 2) is a mitochondrial membrane protein that plays a crucial role in maintaining mitochondrial iron homeostasis and heme biosynthesis. It is primarily localized to the outer mitochondrial membrane and is involved in regulating iron levels within mitochondria, preventing iron overload and ensuring proper mitochondrial function (Mon2018Regulation). SFXN2 is implicated in the transport of serine and other metabolites across the mitochondrial membrane, contributing to one-carbon metabolism and cellular respiration (Kory2018SFXN1).

In healthy human cells, SFXN2 is essential for heme biosynthesis, as its knockout leads to decreased heme content and reduced activities of heme-dependent enzymes, although iron-sulfur cluster-dependent enzyme activities remain unchanged (Mon2018Regulation). This indicates that SFXN2 is specifically involved in heme biosynthesis rather than iron-sulfur cluster assembly. The protein is predominantly expressed in the liver and kidney, organs with high heme-synthesizing capacity, which may be related to their roles in erythropoiesis and detoxification (Mon2018Regulation).

SFXN2 also plays a role in mitochondrial bioenergetics and cellular iron metabolism, contributing to energy production and redox homeostasis (Chen2022Elevated). Its function in serine transport and potential redundancy with other sideroflexin family members, such as SFXN1 and SFXN3, highlights its importance in maintaining mitochondrial function and cellular metabolism (Attwood2021Characterization).

## Clinical Significance
Alterations in the expression of the SFXN2 gene have been implicated in multiple myeloma (MM), a type of hematological cancer. Elevated levels of SFXN2 mRNA are associated with poor outcomes in MM patients, as higher expression correlates with shorter overall survival and increased cancer aggressivity. Overexpression of SFXN2 in MM cell lines leads to increased cell proliferation and colony formation, while knockdown of SFXN2 reduces these effects. SFXN2 is involved in mitochondrial iron metabolism and bioenergetic processes, limiting starvation-induced autophagy and promoting mitochondrial energy production, which supports MM cell proliferation. Inhibition of SFXN2 has shown anti-myeloma activity in vivo, suggesting its potential as a therapeutic target (Chen2022Elevated).

In breast cancer (BC), SFXN2 mRNA levels are significantly upregulated in cancerous tissues compared to normal samples. However, unlike in MM, increased SFXN2 expression in BC is associated with a good prognosis. This suggests that SFXN2 may play different roles in various cancer types, potentially influencing mitochondrial and metabolic processes in BC (Yuan2023Comprehensive).

SFXN2 is also crucial for maintaining mitochondrial iron homeostasis. Knockout studies have shown that loss of SFXN2 leads to abnormal iron accumulation in mitochondria, decreased mitochondrial respiration, and increased susceptibility to iron-mediated cytotoxicity (Mon2018Regulation).

## Interactions
Sideroflexin 2 (SFXN2) is a mitochondrial outer membrane protein that participates in several interactions influencing mitochondrial function and iron metabolism. SFXN2 interacts with heme oxygenase 1 (HO1), a key player in heme catabolism and cytoprotection against oxidative stress. This interaction is significant in the SFXN2-mediated mitophagy pathway, where HO1's inhibition affects autophagy-related protein expression and autophagic flux, suggesting a role in modulating iron-mediated energy production and reactive oxygen species (ROS) generation (Chen2022Elevated).

SFXN2 also interacts with proteins involved in cellular endoplasmic reticulum (ER)-mediated stress and bioenergy metabolic processes. These interactions are crucial for maintaining mitochondrial homeostasis and regulating iron metabolism and ATP production (Chen2022Elevated). The protein's role in suppressing starvation-induced autophagy via the PINK1/PARK pathway further highlights its involvement in maintaining mitochondrial membrane potential and mitophagy (Chen2022Elevated).

Additionally, SFXN2 has been associated with proteins like Mitofusin1 and Timm50, as indicated by Western blotting experiments, suggesting its involvement in mitochondrial processes and potential interactions with these mitochondrial proteins (Mon2018Regulation). These interactions underscore SFXN2's role in regulating mitochondrial bioenergetics and cellular iron metabolism.


## References


[1. (Kory2018SFXN1) Nora Kory, Gregory A. Wyant, Gyan Prakash, Jelmi uit de Bos, Francesca Bottanelli, Michael E. Pacold, Sze Ham Chan, Caroline A. Lewis, Tim Wang, Heather R. Keys, Yang Eric Guo, and David M. Sabatini. Sfxn1 is a mitochondrial serine transporter required for one-carbon metabolism. Science, November 2018. URL: http://dx.doi.org/10.1126/science.aat9528, doi:10.1126/science.aat9528. This article has 161 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aat9528)

[2. (Attwood2021Characterization) Misty M. Attwood and Helgi B. Schiöth. Characterization of five transmembrane proteins: with focus on the tweety, sideroflexin, and yip1 domain families. Frontiers in Cell and Developmental Biology, July 2021. URL: http://dx.doi.org/10.3389/fcell.2021.708754, doi:10.3389/fcell.2021.708754. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.708754)

[3. (Mon2018Regulation) Ei Ei Mon, Fan-Yan Wei, Raja Norazireen Raja Ahmad, Takahiro Yamamoto, Toshiro Moroishi, and Kazuhito Tomizawa. Regulation of mitochondrial iron homeostasis by sideroflexin 2. The Journal of Physiological Sciences, 69(2):359–373, December 2018. URL: http://dx.doi.org/10.1007/s12576-018-0652-2, doi:10.1007/s12576-018-0652-2. This article has 32 citations.](https://doi.org/10.1007/s12576-018-0652-2)

[4. (Chen2022Elevated) Ying Chen, Jinjun Qian, Pinggang Ding, Wang Wang, Xinying Li, Xiaozhu Tang, Chao Tang, Ye Yang, and Chunyan Gu. Elevated sfxn2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation. Cell Death &amp; Disease, September 2022. URL: http://dx.doi.org/10.1038/s41419-022-05272-z, doi:10.1038/s41419-022-05272-z. This article has 5 citations.](https://doi.org/10.1038/s41419-022-05272-z)

[5. (Yuan2023Comprehensive) Ding Yuan, Jialiang Liu, Wenbo Sang, and Qing Li. Comprehensive analysis of the role of sfxn family in breast cancer. Open Medicine, January 2023. URL: http://dx.doi.org/10.1515/med-2023-0685, doi:10.1515/med-2023-0685. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/med-2023-0685)